Physician profile
Grace Hahn
NPI 1376193185
$1,054.74
in general payments reported to CMS, 2019-2025
11 companies · $1,055 in 2025
The $1,055 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,054.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $242.96 | 2025 | Tremfya, Simponi, Stelara |
| Genzyme Corporation | $196.35 | 2025 | |
| Incyte Corporation | $169.51 | 2025 | Opzelura, Opzelura |
| Ucb, INC. | $136.42 | 2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $97.39 | 2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $51.18 | 2025 | |
| Organon LLC | $49.44 | 2025 | |
| Paratek Pharmaceuticals, INC. | $43.77 | 2025 | Nuzyra |
| Helsinn Therapeutics (U.S.), INC. | $27.44 | 2025 | Valchlor |
| Leo Pharma INC. | $22.21 | 2025 | Anzupgo |
| Arcutis Biotherapeutics, INC. | $18.07 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Hahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.